SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001654954-20-006199
Filing Date
2020-06-01
Accepted
2020-06-01 15:55:10
Documents
6
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO 1 biei_10ka.htm 10-K/A 31253
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF biei_ex311.htm EX-31.1 12308
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF biei_ex312.htm EX-31.2 12394
4 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE biei_ex321.htm EX-32.1 7031
5 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE biei_ex322.htm EX-32.2 7209
6 IMAGE biei_ex312000.jpg GRAPHIC 7067
  Complete submission text file 0001654954-20-006199.txt   81062
Mailing Address P.O. BOX 25 JACKSON CENTER PA 16133
Business Address P.O. BOX 25 JACKSON CENTER PA 16133 724-633-7033
PREMIER BIOMEDICAL INC (Filer) CIK: 0001515740 (see all company filings)

IRS No.: 272635666 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-54563 | Film No.: 20933341
SIC: 2836 Biological Products, (No Diagnostic Substances)